Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.

To evaluate the efficacy of oral linezolid, with or without rifampicin, on valve vegetations and secondary foci of infection compared with vancomycin, in the absence or presence of rifampicin, in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Treatment groups were controls (n = 16), linezolid (n = 15), vancomycin (n = 15), linezolid and rifampicin (n = 15), vancomycin and rifampicin (n = 13), linezolid relapse (n = 11) and vancomycin relapse (n = 9). Therapy lasted 5 days in all groups, with survival of animals in the linezolid relapse and vancomycin relapse groups being recorded for an additional 5 days. Blood was drawn to determine the linezolid concentration, and valve vegetations, and kidney, liver, lung and spleen segments were collected for culture.
Survival in each individual group was higher than that in the control group; bacterial load in valve vegetations was reduced by all treatment regimens, with linezolid exhibiting bactericidal effects. Bactericidal activity of linezolid was noted in all secondary foci of infection except the lung, where only the combination of rifampicin with linezolid was bactericidal.
Orally administered linezolid is effective in limiting bacterial growth in the secondary foci of endocarditis. Co-administration of rifampicin favoured the suppression of bacterial growth in the lung.
AuthorsThomas Tsaganos, Ioannis Skiadas, Pantelis Koutoukas, Theodoros Adamis, Nikos Baxevanos, Ira Tzepi, Aimilia Pelekanou, Evangelos J Giamarellos-Bourboulis, Helen Giamarellou, Kyriaki Kanellakopoulou
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 62 Issue 2 Pg. 381-3 (Aug 2008) ISSN: 1460-2091 [Electronic] England
PMID18445576 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetamides
  • Anti-Bacterial Agents
  • Oxazolidinones
  • Vancomycin
  • Linezolid
  • Rifampin
  • Acetamides (pharmacokinetics, pharmacology, therapeutic use)
  • Administration, Oral
  • Animals
  • Anti-Bacterial Agents (pharmacokinetics, pharmacology, therapeutic use)
  • Drug Therapy, Combination
  • Endocarditis, Bacterial (drug therapy, microbiology)
  • Heart Valves (microbiology)
  • Kidney (microbiology)
  • Linezolid
  • Liver (microbiology)
  • Lung (microbiology)
  • Male
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Microbial Viability
  • Models, Animal
  • Oxazolidinones (pharmacokinetics, pharmacology, therapeutic use)
  • Plasma (chemistry)
  • Rabbits
  • Rifampin (pharmacokinetics, pharmacology, therapeutic use)
  • Spleen
  • Staphylococcal Infections (drug therapy, microbiology)
  • Staphylococcus aureus (drug effects, isolation & purification)
  • Survival Analysis
  • Vancomycin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: